Trial Profile
Efficacy and Safety of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension Plus Brimonidine 2 mg/mL Eye Drops, Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2017
Price :
$35
*
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Brimonidine; Brinzolamide
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 01 Dec 2016 Status changed from active, no longer recruiting to completed.
- 28 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Nov 2016.
- 28 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Nov 2016.